Corrigendum: Integrated bioinformatic analysis reveals TXNRD1 as a novel biomarker and potential therapeutic target in idiopathic pulmonary arterial hypertension.

Lin, Wenchao; Tang, Yiyang; Zhang, Mengqiu; Liang, Benhui; Wang, Meijuan; Zha, Lihuang; Yu, Zaixin

Lin, Wenchao; Tang, Yiyang; Zhang, Mengqiu; Liang, Benhui; Wang, Meijuan; Zha, Lihuang; Yu, Zaixin.

Afiliação

Lin W; Department of Cardiology, Xiangya Hospital, Central South University, Changsha, China.
Tang Y; Department of Cardiology, Xiangya Hospital, Central South University, Changsha, China.
Zhang M; Department of Cardiology, Xiangya Hospital, Central South University, Changsha, China.
Liang B; Department of Cardiology, Xiangya Hospital, Central South University, Changsha, China.
Wang M; Department of Cardiology, Xiangya Hospital, Central South University, Changsha, China.
Zha L; Department of Cardiology, Xiangya Hospital, Central South University, Changsha, China.
Yu Z; Department of Cardiology, Xiangya Hospital, Central South University, Changsha, China.

Front Med (Lausanne) ; 9: 1116599, 2022.

Article em En | MEDLINE | ID: mdl-36590941